No connection

Search Results

HTCR vs SONM

HTCR
HeartCore Enterprises, Inc.
BEARISH
Price
$3.40
Market Cap
$4.3M
Sector
Technology
AI Confidence
95%
SONM
DNA X, Inc.
BEARISH
Price
$3.00
Market Cap
$4.5M
Sector
Technology
AI Confidence
95%

Valuation

P/E Ratio
HTCR
--
SONM
--
Forward P/E
HTCR
30.91
SONM
3.57
P/B Ratio
HTCR
20.73
SONM
-4.35
P/S Ratio
HTCR
0.48
SONM
--
EV/EBITDA
HTCR
0.46
SONM
-3.97

Profitability

Gross Margin
HTCR
35.14%
SONM
0.0%
Operating Margin
HTCR
-65.86%
SONM
0.0%
Profit Margin
HTCR
64.6%
SONM
0.0%
ROE
HTCR
-77.88%
SONM
--
ROA
HTCR
-14.44%
SONM
-8.08%

Growth

Revenue Growth
HTCR
35.4%
SONM
--
Earnings Growth
HTCR
--
SONM
--

Financial Health

Debt/Equity
HTCR
0.1
SONM
--
Current Ratio
HTCR
1.58
SONM
0.6
Quick Ratio
HTCR
1.22
SONM
0.03

Dividends

Dividend Yield
HTCR
--
SONM
--
Payout Ratio
HTCR
0.0%
SONM
0.0%

AI Verdict

HTCR BEARISH

HTCR exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating failure across all fundamental health benchmarks. Despite a low debt-to-equity ratio, the company suffers from severe operating losses (-65.86% operating margin) and a catastrophic long-term price collapse of -95.8% over five years. While YoY revenue growth is positive, the recent Q/Q revenue plunge of -44.36% and massive earnings misses suggest a failing business model. The stock is currently in a free-fall technical trend with no fundamental support.

Strengths
Low Debt/Equity ratio (0.10)
Positive Year-over-Year revenue growth (35.40%)
Current Ratio of 1.58 suggests short-term liquidity
Risks
Piotroski F-Score of 0/9 indicates extreme fundamental weakness
Severe operating inefficiency with -65.86% operating margin
Extreme negative shareholder equity return (ROE: -77.88%)
SONM BEARISH

The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental health. With a Quick Ratio of 0.03 and a negative Price-to-Book ratio of -4.35, the firm is facing a severe liquidity crisis and possesses negative shareholders' equity. Catastrophic Q/Q revenue growth of -394.48% and a 5-year price decline of 99.7% suggest a business in terminal decline. The lack of an Altman Z-Score calculation is likely due to the absence of positive working capital or equity, further signaling insolvency risk.

Strengths
Recent reduction in quarterly EPS loss ($-9.36 vs $-25.38)
Low current price relative to 52-week high
Positive YoY EPS growth (though starting from a deep negative base)
Risks
Imminent insolvency risk due to Quick Ratio of 0.03
Negative shareholders' equity (Price/Book -4.35)
Catastrophic collapse in quarterly revenue (-394.48%)

Compare Another Pair

HTCR vs SONM: Head-to-Head Comparison

This page compares HeartCore Enterprises, Inc. (HTCR) and DNA X, Inc. (SONM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile